[go: up one dir, main page]

NO20003393D0 - FremgangsmÕte for fremstilling av en farmasøytisk formulering - Google Patents

FremgangsmÕte for fremstilling av en farmasøytisk formulering

Info

Publication number
NO20003393D0
NO20003393D0 NO20003393A NO20003393A NO20003393D0 NO 20003393 D0 NO20003393 D0 NO 20003393D0 NO 20003393 A NO20003393 A NO 20003393A NO 20003393 A NO20003393 A NO 20003393A NO 20003393 D0 NO20003393 D0 NO 20003393D0
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
NO20003393A
Other languages
English (en)
Other versions
NO20003393L (no
Inventor
Tapio Lankinen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO20003393D0 publication Critical patent/NO20003393D0/no
Publication of NO20003393L publication Critical patent/NO20003393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20003393A 1997-12-31 2000-06-29 FremgangsmÕte for fremstilling av en farmasøytisk formulering NO20003393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI974664A FI105074B (fi) 1997-12-31 1997-12-31 Farmaseuttisen formulaation valmistusmenetelmä
PCT/FI1998/001001 WO1999034778A1 (en) 1997-12-31 1998-12-21 A method for making a pharmaceutical formulation

Publications (2)

Publication Number Publication Date
NO20003393D0 true NO20003393D0 (no) 2000-06-29
NO20003393L NO20003393L (no) 2000-07-31

Family

ID=8550254

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003393A NO20003393L (no) 1997-12-31 2000-06-29 FremgangsmÕte for fremstilling av en farmasøytisk formulering

Country Status (17)

Country Link
US (1) US6616945B1 (no)
EP (1) EP1041971A1 (no)
JP (2) JP4131610B2 (no)
KR (1) KR20010033725A (no)
CN (1) CN1172659C (no)
AU (1) AU754074B2 (no)
CA (1) CA2314112C (no)
DE (1) DE1041971T1 (no)
EE (1) EE04993B1 (no)
FI (1) FI105074B (no)
HU (1) HUP0100398A2 (no)
IL (1) IL137017A0 (no)
NO (1) NO20003393L (no)
NZ (1) NZ505400A (no)
PL (1) PL341410A1 (no)
RU (1) RU2203045C2 (no)
WO (1) WO1999034778A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI116657B (fi) * 2002-03-28 2006-01-31 Focus Inhalation Oy Menetelmä kantoainehiukkasten käsittelemiseksi ja niiden käyttö
PL207752B1 (pl) * 2002-04-04 2011-01-31 Boehringer Ingelheim Pharma Sposób otrzymywania trwałego fizycznie i jednorodnego sproszkowanego preparatu zawierającego tiotropium, sproszkowany preparat i jego zastosowanie
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2009046215A2 (en) * 2007-10-02 2009-04-09 Lab International Srl Safety and abuse deterrent improved device
WO2012053654A1 (en) 2010-10-18 2012-04-26 Dainippon Sumitomo Pharma Co., Ltd. Sustained-release formulation for injection
CN110025578B (zh) * 2019-04-10 2021-06-15 深圳市新阳唯康科技有限公司 一种治疗哮喘类肺部疾病的共无定形粉末及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937303A (en) * 1959-01-02 1963-09-18 Benger Lab Ltd Improvements in and relating to the application of drugs in finely divided condition
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
WO1990013327A1 (en) 1989-04-28 1990-11-15 Riker Laboratories, Inc. Dry powder inhalation device
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
US5393716A (en) * 1992-09-25 1995-02-28 Ecc International Limited Process for producing anti-blocking compositions
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
RU2071317C1 (ru) * 1994-12-21 1997-01-10 Александр Григорьевич Чучалин Лекарственный порошкообразный препарат для ингаляций
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus

Also Published As

Publication number Publication date
CN1172659C (zh) 2004-10-27
IL137017A0 (en) 2001-06-14
JP2008019279A (ja) 2008-01-31
JP2002500176A (ja) 2002-01-08
EP1041971A1 (en) 2000-10-11
PL341410A1 (en) 2001-04-09
EE200000401A (et) 2001-10-15
RU2203045C2 (ru) 2003-04-27
FI974664L (fi) 1999-07-01
AU754074B2 (en) 2002-11-07
WO1999034778A1 (en) 1999-07-15
AU1760899A (en) 1999-07-26
DE1041971T1 (de) 2001-02-08
FI105074B (fi) 2000-06-15
FI974664A0 (fi) 1997-12-31
NO20003393L (no) 2000-07-31
KR20010033725A (ko) 2001-04-25
US6616945B1 (en) 2003-09-09
CA2314112C (en) 2008-06-17
NZ505400A (en) 2003-06-30
EE04993B1 (et) 2008-04-15
CN1283109A (zh) 2001-02-07
JP4131610B2 (ja) 2008-08-13
CA2314112A1 (en) 1999-07-15
HUP0100398A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
NO973938L (no) Farmasöytisk preparat av piperidinoalkanolforbindelser
ID24654A (id) Formulasi farmasi omeprazola
NO973612L (no) Nytt farmasöytisk preparat
NO995533L (no) Ny fremgangsmåte for fremstilling av en farmakologisk aktiv substans
BR9610396A (pt) Formulação farmacêutica
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO973610D0 (no) Nytt farmasöytisk preparat
NO993949D0 (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
FI973230L (fi) Uusi farmaseuttinen formulaatio
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
FI951155A7 (fi) Farmaseuttinen valmiste
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO994793L (no) Fremgangsmåte for fremstilling av clavulansyre
NO982975D0 (no) FremgangsmÕte for fremstilling av fosfatbundne keramer
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application